121 related articles for article (PubMed ID: 26348632)
1. LOXL1 Hypermethylation in Pseudoexfoliation Syndrome in the Uighur Population.
Ye H; Jiang Y; Jing Q; Li D; Maimaiti T; Kasimu D; Lu Y
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5838-43. PubMed ID: 26348632
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
4. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
[TBL] [Abstract][Full Text] [Related]
5. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome.
Papadopoulou M; Papadaki H; Zolota V; Gartaganis SP
Curr Eye Res; 2017 Jun; 42(6):880-889. PubMed ID: 28085506
[TBL] [Abstract][Full Text] [Related]
7. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
[TBL] [Abstract][Full Text] [Related]
8. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
[TBL] [Abstract][Full Text] [Related]
9. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
10. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.
Khan TT; Li G; Navarro ID; Kastury RD; Zeil CJ; Semchyshyn TM; Moya FJ; Epstein DL; Gonzalez P; Challa P
Mol Vis; 2010 Nov; 16():2236-41. PubMed ID: 21139690
[TBL] [Abstract][Full Text] [Related]
11. Differential Lysyl oxidase like 1 expression in pseudoexfoliation glaucoma is orchestrated via DNA methylation.
Greene AG; Eivers SB; McDonnell F; Dervan EWJ; O'Brien CJ; Wallace DM
Exp Eye Res; 2020 Dec; 201():108349. PubMed ID: 33188817
[TBL] [Abstract][Full Text] [Related]
12. The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome.
Berner D; Hoja U; Zenkel M; Ross JJ; Uebe S; Paoli D; Frezzotti P; Rautenbach RM; Ziskind A; Williams SE; Carmichael TR; Ramsay M; Topouzis F; Chatzikyriakidou A; Lambropoulos A; Sundaresan P; Ayub H; Akhtar F; Qamar R; Zenteno JC; Cruz-Aguilar M; Astakhov YS; Dubina M; Wiggs J; Ozaki M; Kruse FE; Aung T; Reis A; Khor CC; Pasutto F; Schlötzer-Schrehardt U
Hum Mol Genet; 2019 Aug; 28(15):2531-2548. PubMed ID: 30986821
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract.
Zhou P; Luo Y; Liu X; Fan L; Lu Y
FASEB J; 2012 Dec; 26(12):4897-902. PubMed ID: 22889833
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
15. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome.
Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE
Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634
[TBL] [Abstract][Full Text] [Related]
16. Altered DNA Methylation and Expression Profiles of 8-Oxoguanine DNA Glycosylase 1 in Lens Tissue from Age-related Cataract Patients.
Wang Y; Li F; Zhang G; Kang L; Qin B; Guan H
Curr Eye Res; 2015; 40(8):815-21. PubMed ID: 25310012
[TBL] [Abstract][Full Text] [Related]
17. Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.
Sharma S; Chataway T; Klebe S; Griggs K; Martin S; Chegeni N; Dave A; Zhou T; Ronci M; Voelcker NH; Mills RA; Craig JE
Mol Vis; 2018; 24():801-817. PubMed ID: 30713420
[TBL] [Abstract][Full Text] [Related]
18. Associations of polymorphisms in LOXL1 and copper chaperone genes with pseudoexfoliation-syndrome-related cataract in a Chinese Uygur population.
Jing Q; Li D; Gao W; Zhang F; Lu Y; Jiang Y
Int Ophthalmol; 2020 Jul; 40(7):1841-1848. PubMed ID: 32253563
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
[TBL] [Abstract][Full Text] [Related]
20. Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma.
Zenkel M; Kruse FE; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5558-66. PubMed ID: 18055805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
